Veradigm | MDRX - Loan Capital

Stock Price
4.31
Daily Change
-0.19 -4.22%
Monthly
-6.30%
Yearly
-15.49%
Q1 Forecast
7.75

Veradigm reported $200.33M in Loan Capital for its fiscal quarter ending in September of 2022.





Loan Capital Change Date
Alcidion AUD 694K 17K Jun/2025
Ambu A/S DKK 14M 448M Dec/2025
Amplifon EUR 1.11B 304.77M Sep/2025
Cardinal Health USD 8.35B 633M Dec/2025
Centene USD 17.35B 194M Dec/2025
Charles River Laboratories USD 2.14B 49.09M Dec/2025
Cigna USD 30.95B 4.47B Sep/2025
Computer Programs Systems USD 161.36M 1.74M Sep/2025
Convatec Group USD 1.18B 211.4M Dec/2024
CVS Health USD 60.5B 6M Dec/2025
Diasorin EUR 472.05M 199.95M Jun/2025
Elevance Health USD 30.8B 376M Dec/2025
General Electric Aerospace USD 18.81B 37M Dec/2025
Gulf Medical Proj AED 4.42M 0 Mar/2025
Humana USD 12.37B 238M Dec/2025
IQVIA Holdings USD 13.88B 1.09B Dec/2025
Laboratory Of America USD 5.15B 800K Dec/2025
Maximus USD 1.51B 227.61M Dec/2025
McKesson USD 5.43B 586M Dec/2025
Med Life RON 1.42B 49.61M Jun/2025
Molina Healthcare USD 3.95B 98M Dec/2025
Omnicell USD 167.6M 302K Dec/2025
Oriola-kd EUR 38.9M 600K Sep/2025
Owens Minor USD 1.9B 89.47M Mar/2025
Quest Diagnostics USD 5.17B 4M Dec/2025
Rede D'or Sao Luiz BRL 44.93B 9.86B Sep/2025
Siemens Healthineers EUR 9.85B 1.49B Dec/2025
Sonova Holding CHF 1.39B 209.8M Jun/2025
Supermax Corporation Bhd MYR 17.61M 3.97M Sep/2025
UnitedHealth USD 72.32B 79M Dec/2025
Veradigm USD 200.33M 431K Sep/2022
Xerox USD 3.48B 785M Jun/2025